Viewing Study NCT02627703


Ignite Creation Date: 2025-12-24 @ 7:18 PM
Ignite Modification Date: 2026-02-21 @ 9:25 PM
Study NCT ID: NCT02627703
Status: UNKNOWN
Last Update Posted: 2016-07-20
First Post: 2015-11-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: (Oncotype DX®) in Estrogen Receptor Positive (ER+) HER-2 Negative (HER 2-) 1-3 Node Positive (pN1) Breast Cancer
Sponsor: British Columbia Cancer Agency
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module